Can clarithromycin be co‑administered with amoxicillin safely and appropriately?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clarithromycin and Amoxicillin Can Be Safely Co-Administered Together

Yes, clarithromycin and amoxicillin can be safely co-administered together—this combination is a cornerstone of multiple evidence-based treatment regimens, particularly for H. pylori eradication and community-acquired pneumonia.

Established Clinical Use

This antibiotic combination has extensive clinical validation across multiple conditions:

H. Pylori Eradication (Primary Indication)

Standard triple therapy combining clarithromycin 500 mg twice daily with amoxicillin 1000 mg twice daily plus a PPI is recommended as first-line therapy when local clarithromycin resistance is below 15-20% 1, 2. This regimen should be administered for 14 days to maximize eradication rates 2, 3. The Maastricht IV/Florence Consensus explicitly endorses this combination, noting that PPI-clarithromycin-amoxicillin (PCA) and PPI-clarithromycin-metronidazole (PCM) regimens are equivalent in efficacy 1.

Community-Acquired Pneumonia

For hospitalized adults with non-severe CAP, combined oral therapy with amoxicillin and a macrolide (clarithromycin) is the preferred treatment 4. Similarly, pediatric guidelines recommend adding a macrolide to a β-lactam antibiotic for children ≥5 years when bacterial versus atypical CAP cannot be distinguished 5.

Pharmacokinetic Interactions

Multiple pharmacokinetic studies demonstrate the safety profile of this combination:

  • Triple therapy with clarithromycin and amoxicillin (plus PPI) shows no clinically significant drug interactions 6, 7, 8. While clarithromycin may modestly increase PPI exposure and vice versa, these changes do not require dosage adjustments 8, 9.

  • Amoxicillin pharmacokinetics remain largely unchanged when combined with clarithromycin 7, 8, 9. One study showed a slight (15.6%) decrease in amoxicillin AUC during triple therapy, but this was not clinically significant 6.

  • The active metabolite 14-OH-clarithromycin may show modest increases (23-32%) when combined with amoxicillin and PPIs, but this does not translate to safety concerns 6, 8.

Safety Considerations

No Direct Drug-Drug Contraindications

The FDA label for clarithromycin does not list amoxicillin as a contraindicated or cautionary co-medication 10. The contraindications for clarithromycin focus on specific drug classes: cisapride, pimozide, ergot alkaloids, colchicine (in renal/hepatic impairment), certain statins, and lurasidone 10.

Tolerability Profile

The combination is generally well-tolerated:

  • Drug adverse effects in pediatric studies ranged from 3-16% with clarithromycin-containing regimens 11
  • All triple therapy regimens in adult studies were described as "well tolerated" 6, 7, 8
  • One case report documented manic episodes with both clarithromycin and amoxicillin-clavulanate separately, suggesting individual susceptibility rather than combination effects 12

Candida Colonization

Both antibiotics can increase gastrointestinal Candida colonization, with the combination causing the highest (though not statistically significant) increase 13. However, this increase is small to moderate and does not preclude safe use in most patients.

Important Caveats

Clarithromycin-Specific Warnings Apply

When using this combination, all standard clarithromycin precautions remain relevant:

  • Avoid in patients with QT prolongation, ventricular arrhythmias, or uncorrected electrolyte abnormalities 14, 10
  • Contraindicated with certain CYP3A4 substrates (statins like lovastatin/simvastatin, colchicine in renal/hepatic impairment) 14, 10
  • Monitor for hepatotoxicity—discontinue immediately if hepatitis symptoms develop 10
  • Dose adjustment required in renal impairment (reduce clarithromycin by 50% if CrCl 30-60 mL/min, by 75% if <30 mL/min) 10

Regional Resistance Patterns Matter

For H. pylori treatment, this combination should only be used empirically when local clarithromycin resistance is <15-20% 1, 2. In high-resistance areas, bismuth-containing quadruple therapy or sequential regimens are preferred 1.

Penicillin Allergy Considerations

For patients with documented penicillin allergy, amoxicillin is contraindicated. However, consider penicillin allergy testing to delist the allergy and enable amoxicillin use, as true anaphylaxis is rare 3.

Practical Dosing Algorithm

For H. pylori eradication:

  • Clarithromycin 500 mg twice daily
  • Amoxicillin 1000 mg twice daily
  • PPI standard dose twice daily
  • Duration: 14 days 2

For community-acquired pneumonia (adults):

  • Amoxicillin 90 mg/kg/day in 2 doses (max 4 g/day)
  • Clarithromycin 500 mg twice daily or 1000 mg extended-release daily
  • Duration: typically 7-10 days 4, 15

For pediatric CAP (≥5 years):

  • Amoxicillin 90 mg/kg/day in 2 doses (max 4 g/day)
  • Clarithromycin 15 mg/kg/day in 2 doses (max 1 g/day) for 7-14 days 5

References

Guideline

perforated and bleeding peptic ulcer: wses guidelines.

World Journal of Emergency Surgery, 2020

Research

Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects.

International journal of clinical pharmacology and therapeutics, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.